Login / Signup

Triple combination targeting methyltransferase, BCL-2, and PD-1 facilitates antileukemia responses in acute myeloid leukemia.

Zhihong ZengAbhishek MaitiShelley HerbrichTianyu CaiAntonio CavazosTaylor ManzellaHelen MaKala HayesJairo MatthewsCourtney D D DiNardoNaval G DaverMarina Y Konopleva
Published in: Cancer (2022)
Immunomodulation by targeting PD-1 enhances the therapeutic effect of combining an HMA and venetoclax in patients with AML.
Keyphrases
  • acute myeloid leukemia
  • cancer therapy
  • chronic lymphocytic leukemia
  • allogeneic hematopoietic stem cell transplantation
  • drug delivery